TY - JOUR
T1 - Group X secretory phospholipase A2 augments angiotensin II-induced inflammatory responses and abdominal aortic aneurysm formation in apoE-deficient mice
AU - Zack, Melissa
AU - Boyanovsky, Boris B.
AU - Shridas, Preetha
AU - Bailey, William
AU - Forrest, Kathy
AU - Howatt, Deborah A.
AU - Gelb, Michael H.
AU - de Beer, Frederick C.
AU - Daugherty, Alan
AU - Webb, Nancy R.
N1 - Funding Information:
This work was supported by NIH grant PO1HL080100 (to NW and AD) and United States Department of Agriculture Fellowship Grant n2005-38420-15825 (to MZ).
PY - 2011/1
Y1 - 2011/1
N2 - Objective: Abdominal aortic aneurysm (AAA) is a complex vascular disease characterized by matrix degradation and inflammation and is a major cause of mortality in older men. Specific interventions that prevent AAA progression remain to be identified. In this study, we tested the hypothesis that Group X secretory phospholipase A 2 (GX sPLA 2), an enzyme implicated in inflammatory processes, mediates AAA. Methods and results: GX sPLA 2 was detected by immunostaining in human aneurysmal tissue and in angiotensin II (Ang II)-induced AAAs in apolipoprotein E-deficient (apoE -/-) mice. GX sPLA 2 mRNA was increased significantly (11-fold) in abdominal aortas of apoE -/- mice in response to Ang II infusion. To define the role of GX sPLA 2 in experimental AAAs, apoE -/- and apoE -/- x GX sPLA 2 -/- (GX DKO) mice were infused with Ang II for either 10 (n=7) or 28 (n=24-26) days. Deficiency of GX sPLA 2 significantly reduced the incidence and severity of AAAs, as assessed by ultrasound measurements in vivo of aortic lumens and by computer-assisted morphometric analyses ex vivo of external diameter. Results from gene expression profiling indicated that the expression of specific matrix metalloproteinases and inflammatory mediators was blunted in aortas from GX DKO mice compared to apoE -/- mice after 10-day Ang II infusion. Ang II induction of cyclooxygenase-2, interleukin-6, matrix metalloproteinase (MMP)-2, MMP-13 and MMP-14 was reduced significantly in GX DKO mice compared to apoE -/- mice. Conclusion: GX sPLA 2 promotes Ang II-induced pathological responses leading to AAA formation.
AB - Objective: Abdominal aortic aneurysm (AAA) is a complex vascular disease characterized by matrix degradation and inflammation and is a major cause of mortality in older men. Specific interventions that prevent AAA progression remain to be identified. In this study, we tested the hypothesis that Group X secretory phospholipase A 2 (GX sPLA 2), an enzyme implicated in inflammatory processes, mediates AAA. Methods and results: GX sPLA 2 was detected by immunostaining in human aneurysmal tissue and in angiotensin II (Ang II)-induced AAAs in apolipoprotein E-deficient (apoE -/-) mice. GX sPLA 2 mRNA was increased significantly (11-fold) in abdominal aortas of apoE -/- mice in response to Ang II infusion. To define the role of GX sPLA 2 in experimental AAAs, apoE -/- and apoE -/- x GX sPLA 2 -/- (GX DKO) mice were infused with Ang II for either 10 (n=7) or 28 (n=24-26) days. Deficiency of GX sPLA 2 significantly reduced the incidence and severity of AAAs, as assessed by ultrasound measurements in vivo of aortic lumens and by computer-assisted morphometric analyses ex vivo of external diameter. Results from gene expression profiling indicated that the expression of specific matrix metalloproteinases and inflammatory mediators was blunted in aortas from GX DKO mice compared to apoE -/- mice after 10-day Ang II infusion. Ang II induction of cyclooxygenase-2, interleukin-6, matrix metalloproteinase (MMP)-2, MMP-13 and MMP-14 was reduced significantly in GX DKO mice compared to apoE -/- mice. Conclusion: GX sPLA 2 promotes Ang II-induced pathological responses leading to AAA formation.
KW - Aneurysm
KW - Atherosclerosis
KW - Inflammation
KW - Interleukins
KW - Metalloproteinases
UR - http://www.scopus.com/inward/record.url?scp=78650850971&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=78650850971&partnerID=8YFLogxK
U2 - 10.1016/j.atherosclerosis.2010.08.054
DO - 10.1016/j.atherosclerosis.2010.08.054
M3 - Article
C2 - 20833395
AN - SCOPUS:78650850971
VL - 214
SP - 58
EP - 64
IS - 1
ER -
